Europe Transcriptomics 麻豆原创 2021-2031 by Component , Technology , Application , End User , and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM1022011

Publication Date:

October 30, 2022

Pages:

121

Publisher:

Grace 麻豆原创 Data

Countries:

Europe [1]

USD 2,580.00

Oncology [2]

Therapeutic [3]

Country Overview (Pharma & Healthcare) [4]

Pharma & Healthcare [5]

Description:

Europe transcriptomics market was valued at $1,479.6 million in 2021 and will grow by 9.9% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure.
Highlighted with 42 tables and 37 figures, this 121-page report 鈥淓urope Transcriptomics 麻豆原创 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Europe transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country.

Based on Component, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Instruments
鈥� Consumables
鈥� Software
鈥� Services

Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Polymerase Chain Reaction (PCR)
鈥� Next-Generation Sequencing
鈥� Microarray
鈥� In-Situ Hybridization (ISH)
鈥� Gene Regulation Technologies
鈥� Other Technologies

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Drug Discovery and Development
鈥� Diagnostics
鈥� Single Cell Analysis
鈥� Gene Expression
鈥� Cell Biology
鈥� Other Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Academic and Research Institutions
鈥� Biotechnology and Biopharmaceutical Companies
鈥� Contract Research Organizations (CROs)
鈥� Other End Users

Geographically, the following national/local markets are fully investigated:
鈥� Germany
鈥� UK
鈥� France
鈥� Spain
鈥� Italy
鈥� Netherlands
鈥� Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of 麻豆原创 Research Methodology 12
1.2.2 麻豆原创 Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 麻豆原创 Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 麻豆原创 Overview and Dynamics 20
2.1 麻豆原创 Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the 麻豆原创 23
2.2 Major Growth Drivers 25
2.3 麻豆原创 Restraints and Challenges 30
2.4 Emerging Opportunities and 麻豆原创 Trends 33
2.5 Porter鈥檚 Fiver Forces Analysis 37
3 Segmentation of Europe 麻豆原创 by Component 41
3.1 麻豆原创 Overview by Component 41
3.2 Instruments 43
3.3 Consumables 45
3.4 Software 47
3.5 Services 49
4 Segmentation of Europe 麻豆原创 by Technology 50
4.1 麻豆原创 Overview by Technology 50
4.2 Polymerase Chain Reaction (PCR) 52
4.3 Next-Generation Sequencing 54
4.4 Microarray 56
4.5 In-Situ Hybridization (ISH) 58
4.6 Gene Regulation Technologies 60
4.7 Other Technologies 61
5 Segmentation of Europe 麻豆原创 by Application 62
5.1 麻豆原创 Overview by Application 62
5.2 Drug Discovery and Development 64
5.3 Diagnostics 65
5.4 Single Cell Analysis 66
5.5 Gene Expression 67
5.6 Cell Biology 68
5.7 Other Applications 69
6 Segmentation of Europe 麻豆原创 by End User 70
6.1 麻豆原创 Overview by End User 70
6.2 Academic and Research Institutions 72
6.3 Biotechnology and Biopharmaceutical Companies 73
6.4 Contract Research Organizations (CROs) 74
6.5 Other End Users 75
7 European 麻豆原创 2021-2031 by Country 76
7.1 Overview of European 麻豆原创 76
7.2 Germany 79
7.3 U.K. 81
7.4 France 83
7.5 Spain 85
7.6 Italy 87
7.7 Netherlands 89
7.8 Rest of European 麻豆原创 91
8 Competitive Landscape 93
8.1 Overview of Key Vendors 93
8.2 New Product Launch, Partnership, Investment, and M&A 98
8.3 Company Profiles 99
10x Genomics 99
Agilent Technologies, Inc. 101
ANGLE plc 102
Becton, Dickinson and Company (BD) 103
Bio-Rad Laboratories, Inc. 104
BioSypder, Inc. 105
Bio-Techne 106
Cytiva 107
F. Hoffmann-La Roche Ltd. 108
Fluidigm Corporation 109
GE Healthcare 110
Illumina, Inc. 111
Menarini Silicon Biosystems 112
Merck & Co., Inc. 113
NanoString 114
Pacific Biosciences of California, Inc. 115
PerkinElmer Inc. 116
Promega Corporation 117
Qiagen N. V. 118
Takara Bio Inc. 119
Thermo Fisher Scientific Inc. 120
RELATED REPORTS 121

Companies Mentioned:

Selected Key Players:
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.